EET_Promotion_Health_Recruitment_11-01-2023

The CDC has recommended prioritizing infants at the highest risk for severe RSV owing to the short supply of monoclonal antibody nirsevimab.

Dear Reader,  We are proud to introduce you to one of our most popular flagship newsletters: Rise & Shine. Produced by Epoch Health with love, Rise & Shine is your daily source for vital health news and useful health tips.   We are committed to keeping you informed without any censorship, so you can make informed decisions about your well-being.   Join us today and embark on a journey toward a healthier, more informed, and empowered you.   Warm regards, Sign Up for FREE → Top Articles Featured in the Newsletter MOST READ CDC Issues New Vaccine Warning Sign Up to Read MOST SHARED Popular Drink Can Inactivate COVID Omicron Subvariants Sign Up to Read TOP SHARED Terrible New Finding 48 Hours After mRNA Vaccination Sign Up to Read TOP READ Major Updates for Americans Over 65 Sign Up to Read NEW RELEASE Alarming Trend About the Deadliest Cancer Sign Up to Read Share this email with a friend. Forward Received this email from a friend? Subscribe Trouble viewing this email? View in browser Manage Your Email Preferences  Copyright © 2023 The Epoch Times. All rights reserved. The Epoch Times. 229 W. 28 St. Fl. 7 New York, NY 10001   The information in this newsletter is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of many experts and journalists. The Epoch Times encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional. Terms & Conditions | Customer Service | Privacy Policy | Unsubscribe